Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV)
Tóm tắt
Varicella zoster virus (VZV) is a ubiquitous neurotropic human herpesvirus. Primary infection usually causes varicella (chicken pox), after which virus becomes latent in ganglia along the entire neuraxis. Decades later, virus reactivates to produce herpes zoster (shingles), a painful dermatomally distributed vesicular eruption. Zoster may be further complicated by postherpetic neuralgia, VZV vasculopathy, myelitis, and segmental motor weakness. VZV reactivation has also been associated with giant cell arteritis. This overview discusses treatment of various conditions that often require both corticosteroids and antiviral drugs. Treatment for VZV-associated disease is often based on case reports and small studies rather than large-scale clinical trials. Issues that require resolution include the optimal duration of such combined therapy, more effective treatment for postherpetic neuralgia, whether some treatments should be given orally or intravenously, the widening spectrum of zoster sine herpete, and the role of antiviral therapy in giant cell arteritis.
Tài liệu tham khảo
Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 2000; 342:635-645.
Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PGE. Herpes simplex virus-1 and varicella-zoster virus latency in human ganglia. J Neurovirol 2003;9:194-204.
Kennedy PGE, Cohrs RJ Varicella-zoster virus human ganglionic latency—a current summary. J Neurovirol 2010;16:411-418.
Kennedy PGE, Grinfeld E, Gow JW. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A 1998;95:4658-4662.
Ouwendijk WJ, Choe A, Nagel MA, et al. Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J Virol 2012;86: 10203–10206.
Kennedy PGE, Grinfeld E, Bell JE. Varicella-zoster virus gene expression in latently infected human trigeminal ganglia. J Virol 2000;74:11893-11898.
Kennedy PGE, Rovnak J, Badani H, Cohrs RJ. A comparison of HSV-1 and VZV latency and reactivation. J Gen Virol 2015; 96:1581-602.
Cohrs RJ, Randall J, Smith J, et al. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol 2000;74: 11464–11471.
Nagel MA, Choe A, Traktinskiy I, Cordery-Cotter R, Gilden D, Cohrs RJ. Varicella-zoster virus transcriptome in latently infected human ganglia. J Virol 2011; 85:2276-2287.
Steiner I, Budka,H, Chaudhuri A, et al. Viral encephalitis: guidelines for diagnosis and management. Eur J Neurol 2005; 12:331-343.
Wareham DW, Breuer J. Herpes zoster. BMJ 2007; 334:1211-1215.
Gershon A, Breuer J, Cohen J, et al. Varicella zoster virus infection. Nat Rev Primers 2015; 1: 15016.
Acosta EP, Balfour HH. Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics. Antimicrob Agents Chemother 2001; 45: 2771–2774.
Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2008;47:303-327.
Kennedy PGE, Montague P, Scott F, et al .Varicella-zoster viruses associated with post-herpetic neuralgia induce sodium current density increases in the ND7-23 Nav-1.8 neuroblastoma cell line. PLoS ONE 2013; 8 :e51570.
Gilden DH, Cohrs RJ, Mahalingam R.VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology 2005; 64: 21-25.
Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage 2004; 28:396-411.
Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Practice parameter: treatment of postherpetic neuralgia. An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 63:959–965.
Johnson RW, Rice ASC. Postherpetic neuralgia. N Engl J Med 2014; 371:1526-1533.
Quan D, Hammack BN, Kittelson J, Gilden DH. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir Arch Neurol 2006; 63:940-942.
Mahalingam R, Wellish M, Brucklier J, Gilden DH Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol 1995; 1:130-133.
Oxman MN, Levin MJ, Johnson GR, et al A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-2284.
Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 2015;372:2087-2096
Nagel MA, Gilden D. Update on varicella zoster virus vasculopathy. Curr Infect Dis Rep 2014; 16:407.
Nagel MA, Forghani B, Mahalingam R, et al The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007; 68:1069-1073.
Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, Hedley-Whyte ET, Rentier B, Mahalingam R. Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology 1996 ;47:1441-1446.
Kennedy PGE. Neurological complications of varicella-zoster virus infections. In Kennedy PGE, Johnson RT (eds) Infections of the Nervous System. Butterworths, 1987; 177-208.
Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. Zoster sine herpete, a clinical variant Ann Neurol 1994; 35:530-533.
Kennedy PGE. Zoster sine herpete: it would be rash to ignore it. Neurology 2011; 76:416-417.
Smith JH, Swanson JW. Giant cell arteritis. Headache 2014;54:1273-1289.
Kennedy PGE, Lipton HL Varicella-zoster virus claims yet another painful scalp: giant cell arteritis. Neurology 2015; 84: 1918-1919.
Gilden D, White T, Khmeleva N, et al Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 2015; 84:1948-1955.
Nagel MA, White T, Khmeleva N, et al. Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol 2015; 72:1281-1287.